Gemcitabine May Delay Pancreatic Cancer Return

CHICAGO (AP) -- Offering a glint of hope for treating a notorious killer, researchers found that a common chemotherapy drug can help pancreatic cancer patients who have undergone surgery stave off a return of the disease longer.

MORE ON THIS TOPIC